The Cure Starts Now has funded $23,591,110 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 17 countries.




Cincinnati Children's Hospital – $93,250

Amount
$93,250.00
Date
March 2024

SUMOylation as a novel therapeutic target in DIPG

University of Chicago Medical Center – $100,000

Amount
$100,000.00
Date
December 2023

Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.

Icahn School of Medicine at Mount Sinai – $100,000

Amount
$100,000.00
Date
December 2023

Targeting macrophages to improve the survival of DIPG

Children’s Cancer Institute – $50,000

Amount
$50,000.00
Date
December 2023

A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.

Children’s Hospital Colorado – $100,000

Amount
$100,000.00
Date
December 2023

Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.

University of Newcastle – $116,997

Amount
$116,997.00
Date
December 2023

(2023) Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies.

Princess Máxima Center for Pediatric Oncology – $98,306

Amount
$98,306.00
Date
December 2023

Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.

Nemours Children’s Hospital - $50,000

Amount
$50,000.00
Date
December 2023

Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.

Icahn School of Medicine at Mount Sinai - $100,000

Amount
$100,000.00
Date
December 2023

Preclinical evaluation of TP-0184 in an autochthonous mouse model of DIPG/DMG

The University of Alabama at Birmingham – $100,000

Amount
$100,000.00
Date
December 2023

Intranasal Delivery of Targeting Nanotherapeutics for DIPG

Funding of PBTCF 2023 - $25,000

Amount
$25,000.00
Date
December 2023

Children's Cancer Institute – $181,736 USD, $282,633 AUD

Amount
$181,736.00
Date
November 2023

Targeting post-translational protein modification to halt Diffuse Intrinsic Pontine Glioma tumorgenicity

Memorial Sloan Kettering Cancer Center – $100,000

Amount
$100,000.00
Date
November 2023

CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors

University of Colorado Denver – $200,000

Amount
$200,000.00
Date
November 2023

Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma

SIOPe DIPG/DMG Registry – $772,971 USD, € 723,276

Amount
$772,971.00
Date
November 2023

Renewal of the European DIPG/DMG Registry